| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.539 | 0.017 | 0.62 | GABA C receptor rho-3 antagonist | 0.437 0.046 DBMET02152 0.539 0.017 DBMET02153 0.62 0.005 DBMET02164 0.453 0.041 DBMET02150 0.337 0.093 DBMET02151 | DBMET02164 | |
| 0.537 | 0.02 | 0.537 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.414 0.089 DBMET02152 0.537 0.02 DBMET02153 0.424 0.08 DBMET02164 0.384 0.115 DBMET02150 0.3 0.213 DBMET02151 | ||
| 0.333 | 0.012 | 0.333 | Nav1.2 sodium channel blocker | 0.21 0.031 DBMET02152 0.333 0.012 DBMET02153 0.162 0.051 DBMET02164 0.117 0.087 DBMET02150 0.123 0.08 DBMET02151 | ||
| 0.352 | 0.036 | 0.388 | Superoxide dismutase inhibitor | 0.371 0.032 DBMET02152 0.352 0.036 DBMET02153 0.388 0.029 DBMET02164 | DBMET02164 | |
| 0.325 | 0.037 | 0.325 | Psychostimulant | 0.207 0.076 DBMET02152 0.325 0.037 DBMET02153 0.224 0.068 DBMET02164 0.188 0.087 DBMET02151 | ||
| 0.303 | 0.032 | 0.404 | Tyrosine 3 hydroxylase inhibitor | 0.333 0.02 DBMET02152 0.303 0.032 DBMET02153 0.404 0.008 DBMET02164 0.275 0.048 DBMET02150 0.244 0.074 DBMET02151 | DBMET02164 | |
| 0.333 | 0.064 | 0.333 | Vasodilator, coronary | 0.308 0.081 DBMET02152 0.333 0.064 DBMET02153 0.255 0.13 DBMET02164 | ||
| 0.28 | 0.017 | 0.371 | Nitric-oxide synthase stimulant | 0.281 0.017 DBMET02152 0.28 0.017 DBMET02153 0.371 0.004 DBMET02164 0.27 0.021 DBMET02150 0.231 0.048 DBMET02151 | DBMET02164 | |
| 0.368 | 0.109 | 0.368 | Beta lactamase inhibitor | 0.208 0.18 DBMET02152 0.368 0.109 DBMET02153 | ||
| 0.273 | 0.017 | 0.273 | Toll-Like receptor 9 antagonist | 0.148 0.064 DBMET02152 0.273 0.017 DBMET02153 | ||
| 0.357 | 0.109 | 0.554 | 5 Hydroxytryptamine release inhibitor | 0.287 0.18 DBMET02152 0.357 0.109 DBMET02153 0.554 0.019 DBMET02164 0.242 0.24 DBMET02150 | DBMET02164 | |
| 0.287 | 0.043 | 0.357 | Gastrin inhibitor | 0.21 0.134 DBMET02152 0.287 0.043 DBMET02153 0.357 0.009 DBMET02164 | DBMET02164 | |
| 0.285 | 0.042 | 0.285 | Sigma receptor agonist | 0.191 0.065 DBMET02152 0.285 0.042 DBMET02153 | ||
| 0.362 | 0.128 | 0.382 | MAP kinase 1 inhibitor | 0.382 0.117 DBMET02152 0.362 0.128 DBMET02153 | DBMET02152 | |
| 0.242 | 0.018 | 0.242 | Toll-Like receptor antagonist | 0.152 0.054 DBMET02152 0.242 0.018 DBMET02153 | ||
| 0.36 | 0.138 | 0.36 | Caspase 9 stimulant | 0.338 0.155 DBMET02152 0.36 0.138 DBMET02153 0.322 0.17 DBMET02164 | ||
| 0.243 | 0.031 | 0.243 | 3C-like protease (Human coronavirus) inhibitor | 0.147 0.106 DBMET02152 0.243 0.031 DBMET02153 0.233 0.035 DBMET02164 0.153 0.097 DBMET02150 | ||
| 0.219 | 0.011 | 0.219 | Dopamine D4 antagonist | 0.152 0.017 DBMET02152 0.219 0.011 DBMET02153 | ||
| 0.275 | 0.067 | 0.275 | Ca(v)3.3 blocker | 0.206 0.179 DBMET02152 0.275 0.067 DBMET02153 | ||
| 0.284 | 0.076 | 0.284 | Spasmolytic | 0.27 0.083 DBMET02152 0.284 0.076 DBMET02153 0.223 0.104 DBMET02150 | ||
| 0.31 | 0.108 | 0.331 | Calpain 2 inhibitor | 0.207 0.182 DBMET02152 0.31 0.108 DBMET02153 0.331 0.096 DBMET02164 | DBMET02164 | |
| 0.198 | 0.011 | 0.198 | Dopamine D3 antagonist | 0.143 0.016 DBMET02152 0.198 0.011 DBMET02153 0.09 0.028 DBMET02150 | ||
| 0.221 | 0.035 | 0.221 | 5 Hydroxytryptamine 3E antagonist | 0.221 0.035 DBMET02153 0.164 0.157 DBMET02164 0.174 0.122 DBMET02150 | ||
| 0.206 | 0.022 | 0.206 | Alpha 2b adrenoreceptor antagonist | 0.133 0.048 DBMET02152 0.206 0.022 DBMET02153 0.128 0.052 DBMET02150 | ||
| 0.189 | 0.007 | 0.189 | Epoxide hydrolase inhibitor | 0.111 0.02 DBMET02152 0.189 0.007 DBMET02153 0.116 0.018 DBMET02164 0.065 0.061 DBMET02150 | ||
| 0.186 | 0.01 | 0.186 | Cannabinoid receptor antagonist | 0.072 0.047 DBMET02152 0.186 0.01 DBMET02153 | ||
| 0.253 | 0.078 | 0.454 | 5 Hydroxytryptamine uptake stimulant | 0.253 0.077 DBMET02152 0.253 0.078 DBMET02153 0.454 0.007 DBMET02164 0.201 0.15 DBMET02150 | DBMET02164 | |
| 0.197 | 0.026 | 0.287 | Adenylate cyclase inhibitor | 0.287 0.015 DBMET02152 0.197 0.026 DBMET02153 0.222 0.022 DBMET02164 | DBMET02152 | |
| 0.175 | 0.005 | 0.175 | CC chemokine 2 receptor antagonist | 0.124 0.009 DBMET02152 0.175 0.005 DBMET02153 0.068 0.026 DBMET02164 | ||
| 0.249 | 0.08 | 0.297 | Interleukin agonist | 0.218 0.104 DBMET02152 0.249 0.08 DBMET02153 0.297 0.049 DBMET02164 | DBMET02164 | |
| 0.193 | 0.033 | 0.258 | GABA C receptor rho-2 antagonist | 0.139 0.09 DBMET02152 0.193 0.033 DBMET02153 0.258 0.01 DBMET02164 0.155 0.067 DBMET02150 0.133 0.1 DBMET02151 | DBMET02164 | |
| 0.162 | 0.003 | 0.163 | Phospholipase D inhibitor | 0.141 0.004 DBMET02152 0.162 0.003 DBMET02153 0.163 0.002 DBMET02164 0.113 0.009 DBMET02150 0.083 0.03 DBMET02151 | DBMET02164 | |
| 0.163 | 0.009 | 0.163 | Dopamine D4 agonist | 0.083 0.019 DBMET02152 0.163 0.009 DBMET02153 | ||
| 0.222 | 0.069 | 0.222 | ErbB-1 antagonist | 0.204 0.084 DBMET02152 0.222 0.069 DBMET02153 | ||
| 0.177 | 0.024 | 0.177 | Calcium channel N-type blocker | 0.109 0.079 DBMET02152 0.177 0.024 DBMET02153 | ||
| 0.157 | 0.004 | 0.157 | Potassium channel (Tandem pore domain) blocker | 0.089 0.018 DBMET02152 0.157 0.004 DBMET02153 0.086 0.022 DBMET02164 0.089 0.018 DBMET02150 | ||
| 0.241 | 0.094 | 0.259 | 5 Hydroxytryptamine release stimulant | 0.241 0.094 DBMET02153 0.259 0.085 DBMET02164 | DBMET02164 | |
| 0.183 | 0.037 | 0.183 | Anesthetic local | 0.124 0.064 DBMET02152 0.183 0.037 DBMET02153 | ||
| 0.149 | 0.008 | 0.267 | Glycine transporter 2 inhibitor | 0.129 0.009 DBMET02152 0.149 0.008 DBMET02153 0.267 0.004 DBMET02164 0.05 0.031 DBMET02150 | DBMET02164 | |
| 0.205 | 0.065 | 0.205 | Focal adhesion kinase 2 inhibitor | 0.205 0.065 DBMET02153 | ||
| 0.147 | 0.008 | 0.147 | Cannabinoid CB1 receptor antagonist | 0.057 0.049 DBMET02152 0.147 0.008 DBMET02153 | ||
| 0.219 | 0.082 | 0.219 | MAP-kinase-activated kinase 5 inhibitor | 0.178 0.135 DBMET02152 0.219 0.082 DBMET02153 0.17 0.149 DBMET02151 | ||
| 0.145 | 0.011 | 0.145 | Cannabinoid CB1 receptor agonist | 0.053 0.049 DBMET02152 0.145 0.011 DBMET02153 0.083 0.027 DBMET02164 | ||
| 0.162 | 0.029 | 0.162 | 5 Hydroxytryptamine 3A agonist | 0.162 0.029 DBMET02153 | ||
| 0.22 | 0.088 | 0.22 | Neuropeptide Y2 antagonist | 0.184 0.152 DBMET02152 0.22 0.088 DBMET02153 0.22 0.088 DBMET02164 | ||
| 0.18 | 0.049 | 0.18 | Hexokinase inhibitor | 0.16 0.068 DBMET02152 0.18 0.049 DBMET02153 0.166 0.061 DBMET02164 | ||
| 0.139 | 0.008 | 0.139 | Calcium channel T-type blocker | 0.056 0.044 DBMET02152 0.139 0.008 DBMET02153 | ||
| 0.145 | 0.014 | 0.145 | Cannabinoid receptor agonist | 0.145 0.014 DBMET02153 | ||
| 0.158 | 0.029 | 0.158 | Alpha 2c adrenoreceptor antagonist | 0.115 0.053 DBMET02152 0.158 0.029 DBMET02153 0.085 0.081 DBMET02150 | ||
| 0.171 | 0.044 | 0.171 | Calcium channel blocker | 0.171 0.044 DBMET02153 | ||
| 0.238 | 0.117 | 0.255 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.201 0.156 DBMET02152 0.238 0.117 DBMET02153 0.255 0.101 DBMET02151 | DBMET02151 | |
| 0.124 | 0.005 | 0.124 | Dopamine D3 agonist | 0.109 0.006 DBMET02152 0.124 0.005 DBMET02153 | ||
| 0.152 | 0.033 | 0.152 | Calcium channel (voltage-sensitive) blocker | 0.152 0.033 DBMET02153 | ||
| 0.163 | 0.044 | 0.198 | Toll-Like receptor 2 antagonist | 0.186 0.03 DBMET02152 0.163 0.044 DBMET02153 0.198 0.025 DBMET02164 | DBMET02164 | |
| 0.124 | 0.007 | 0.124 | CC chemokine 3 receptor antagonist | 0.049 0.024 DBMET02152 0.124 0.007 DBMET02153 0.043 0.028 DBMET02164 | ||
| 0.144 | 0.028 | 0.154 | Transcription factor STAT6 inhibitor | 0.154 0.02 DBMET02152 0.144 0.028 DBMET02153 0.108 0.084 DBMET02164 | DBMET02152 | |
| 0.223 | 0.108 | 0.223 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.223 0.108 DBMET02153 | ||
| 0.163 | 0.049 | 0.163 | Sodium channel blocker | 0.163 0.049 DBMET02153 | ||
| 0.142 | 0.03 | 0.142 | Sphingosine 1-phosphate receptor 2 agonist | 0.108 0.08 DBMET02152 0.142 0.03 DBMET02153 0.142 0.031 DBMET02164 | ||
| 0.146 | 0.035 | 0.146 | DNA repair enzyme inhibitor | 0.133 0.051 DBMET02152 0.146 0.035 DBMET02153 | ||
| 0.274 | 0.162 | 0.274 | MAP kinase kinase 6 inhibitor | 0.274 0.162 DBMET02153 | ||
| 0.119 | 0.009 | 0.119 | 5 Hydroxytryptamine 3A antagonist | 0.119 0.009 DBMET02153 | ||
| 0.28 | 0.173 | 0.28 | DNA directed DNA polymerase inhibitor | 0.249 0.192 DBMET02152 0.28 0.173 DBMET02153 0.267 0.181 DBMET02164 | ||
| 0.112 | 0.005 | 0.112 | 5 Hydroxytryptamine 4 antagonist | 0.085 0.011 DBMET02152 0.112 0.005 DBMET02153 0.049 0.039 DBMET02151 | ||
| 0.135 | 0.028 | 0.156 | Dopamine antagonist | 0.156 0.025 DBMET02152 0.135 0.028 DBMET02153 | DBMET02152 | |
| 0.111 | 0.004 | 0.111 | CC chemokine 4 receptor antagonist | 0.055 0.02 DBMET02152 0.111 0.004 DBMET02153 | ||
| 0.165 | 0.059 | 0.308 | Heat shock protein 90 antagonist | 0.308 0.009 DBMET02152 0.165 0.059 DBMET02153 | DBMET02152 | |
| 0.217 | 0.111 | 0.217 | 5 Hydroxytryptamine 1E antagonist | 0.217 0.111 DBMET02153 0.18 0.154 DBMET02164 | ||
| 0.129 | 0.023 | 0.129 | Toll-Like receptor 3 antagonist | 0.093 0.062 DBMET02152 0.129 0.023 DBMET02153 | ||
| 0.143 | 0.04 | 0.143 | Falcipain 3 inhibitor | 0.092 0.079 DBMET02152 0.143 0.04 DBMET02153 0.136 0.044 DBMET02164 | ||
| 0.118 | 0.015 | 0.118 | Cannabinoid CB2 receptor agonist | 0.118 0.015 DBMET02153 | ||
| 0.138 | 0.035 | 0.138 | Nav1.5 sodium channel blocker | 0.138 0.035 DBMET02153 | ||
| 0.126 | 0.025 | 0.168 | Lanosterol 14 alpha demethylase inhibitor | 0.126 0.025 DBMET02153 0.168 0.007 DBMET02164 0.091 0.07 DBMET02150 | DBMET02164 | |
| 0.231 | 0.131 | 0.338 | Thyroid hormone beta antagonist | 0.236 0.127 DBMET02152 0.231 0.131 DBMET02153 0.338 0.073 DBMET02164 | DBMET02164 | |
| 0.109 | 0.009 | 0.207 | Heat shock protein 90 beta antagonist | 0.207 0.004 DBMET02152 0.109 0.009 DBMET02153 0.061 0.038 DBMET02164 | DBMET02152 | |
| 0.203 | 0.103 | 0.611 | Aldehyde oxidase inhibitor | 0.221 0.094 DBMET02152 0.203 0.103 DBMET02153 0.611 0.018 DBMET02164 | DBMET02164 | |
| 0.112 | 0.012 | 0.112 | Cannabinoid CB2 receptor antagonist | 0.066 0.025 DBMET02152 0.112 0.012 DBMET02153 | ||
| 0.128 | 0.028 | 0.128 | MAP kinase kinase 1 inhibitor | 0.116 0.039 DBMET02152 0.128 0.028 DBMET02153 | ||
| 0.206 | 0.108 | 0.239 | Calpain inhibitor | 0.167 0.152 DBMET02152 0.206 0.108 DBMET02153 0.239 0.076 DBMET02164 | DBMET02164 | |
| 0.194 | 0.096 | 0.194 | Potassium channel blocker | 0.194 0.096 DBMET02153 0.155 0.13 DBMET02150 | ||
| 0.151 | 0.054 | 0.151 | Sodium channel (voltage-gated) blocker | 0.151 0.054 DBMET02153 | ||
| 0.097 | 0.003 | 0.097 | Calcium-sensing receptor agonist | 0.073 0.004 DBMET02152 0.097 0.003 DBMET02153 0.062 0.004 DBMET02164 | ||
| 0.155 | 0.063 | 0.173 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.173 0.039 DBMET02152 0.155 0.063 DBMET02153 | DBMET02152 | |
| 0.128 | 0.037 | 0.128 | Acetylcholine release stimulant | 0.128 0.037 DBMET02153 | ||
| 0.123 | 0.033 | 0.157 | Interleukin 1 beta converting enzyme inhibitor | 0.11 0.045 DBMET02152 0.123 0.033 DBMET02153 0.157 0.015 DBMET02164 | DBMET02164 | |
| 0.171 | 0.083 | 0.171 | MAP kinase kinase 5 inhibitor | 0.165 0.099 DBMET02152 0.171 0.083 DBMET02153 | ||
| 0.162 | 0.076 | 0.287 | Heat shock protein 90 alpha antagonist | 0.287 0.017 DBMET02152 0.162 0.076 DBMET02153 | DBMET02152 | |
| 0.094 | 0.009 | 0.096 | MDM2 inhibitor | 0.078 0.023 DBMET02152 0.094 0.009 DBMET02153 0.096 0.008 DBMET02164 | DBMET02164 | |
| 0.098 | 0.014 | 0.098 | Melanin-concentrating hormone receptor 1 antagonist | 0.098 0.014 DBMET02153 | ||
| 0.1 | 0.017 | 0.106 | Vanilloid 4 agonist | 0.072 0.06 DBMET02152 0.1 0.017 DBMET02153 0.106 0.013 DBMET02164 0.076 0.049 DBMET02150 | DBMET02164 | |
| 0.15 | 0.067 | 0.15 | MAP kinase 3 inhibitor | 0.126 0.118 DBMET02152 0.15 0.067 DBMET02153 0.137 0.091 DBMET02164 | ||
| 0.142 | 0.06 | 0.158 | NADPH oxidase inhibitor | 0.148 0.055 DBMET02152 0.142 0.06 DBMET02153 0.158 0.049 DBMET02164 | DBMET02164 | |
| 0.086 | 0.004 | 0.116 | LFA antagonist | 0.032 0.014 DBMET02152 0.086 0.004 DBMET02153 0.116 0.003 DBMET02164 0.029 0.017 DBMET02150 | DBMET02164 | |
| 0.119 | 0.037 | 0.283 | Electrolyte absorption antagonist | 0.119 0.037 DBMET02153 0.283 0.004 DBMET02164 0.094 0.068 DBMET02151 | DBMET02164 | |
| 0.163 | 0.081 | 0.231 | ATPase inhibitor | 0.163 0.081 DBMET02153 0.231 0.019 DBMET02164 | DBMET02164 | |
| 0.111 | 0.029 | 0.111 | Bromodomain-containing protein 2 inhibitor | 0.111 0.029 DBMET02153 0.086 0.063 DBMET02164 | ||
| 0.128 | 0.047 | 0.128 | EphA2 antagonist | 0.11 0.065 DBMET02152 0.128 0.047 DBMET02153 | ||
| 0.188 | 0.107 | 0.219 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.219 0.09 DBMET02152 0.188 0.107 DBMET02153 0.186 0.109 DBMET02164 | DBMET02152 | |
| 0.166 | 0.086 | 0.348 | Succinate dehydrogenase inhibitor | 0.179 0.068 DBMET02152 0.166 0.086 DBMET02153 0.348 0.005 DBMET02164 0.152 0.109 DBMET02150 | DBMET02164 | |
| 0.135 | 0.055 | 0.135 | Proteasome inhibitor | 0.102 0.085 DBMET02152 0.135 0.055 DBMET02153 0.113 0.071 DBMET02164 | ||
| 0.12 | 0.041 | 0.141 | Creatine kinase inhibitor | 0.137 0.03 DBMET02152 0.12 0.041 DBMET02153 0.141 0.028 DBMET02164 | DBMET02164 | |
| 0.092 | 0.013 | 0.136 | Glycine transporter inhibitor | 0.092 0.013 DBMET02153 0.136 0.006 DBMET02164 | DBMET02164 | |
| 0.13 | 0.053 | 0.13 | 5 Hydroxytryptamine 2 antagonist | 0.13 0.053 DBMET02153 | ||
| 0.136 | 0.06 | 0.136 | Antibacterial (Helicobacter pylori) | 0.136 0.06 DBMET02153 0.109 0.101 DBMET02164 | ||
| 0.146 | 0.071 | 0.146 | Neuropeptide Y1 antagonist | 0.146 0.071 DBMET02153 | ||
| 0.147 | 0.072 | 0.174 | Thiol protease inhibitor | 0.121 0.115 DBMET02152 0.147 0.072 DBMET02153 0.174 0.052 DBMET02164 | DBMET02164 | |
| 0.082 | 0.007 | 0.082 | Adenylate cyclase 1 inhibitor | 0.059 0.018 DBMET02152 0.082 0.007 DBMET02153 0.076 0.009 DBMET02164 | ||
| 0.102 | 0.027 | 0.108 | Dopamine agonist | 0.108 0.024 DBMET02152 0.102 0.027 DBMET02153 | DBMET02152 | |
| 0.127 | 0.054 | 0.719 | DNA intercalator | 0.1 0.073 DBMET02152 0.127 0.054 DBMET02153 0.719 0.003 DBMET02150 0.621 0.004 DBMET02151 | DBMET02150 | |
| 0.219 | 0.146 | 0.357 | Thyroid hormone antagonist | 0.232 0.136 DBMET02152 0.219 0.146 DBMET02153 0.357 0.071 DBMET02164 | DBMET02164 | |
| 0.202 | 0.136 | 0.247 | Transcription factor STAT inhibitor | 0.247 0.089 DBMET02152 0.202 0.136 DBMET02153 0.204 0.132 DBMET02164 | DBMET02152 | |
| 0.1 | 0.035 | 0.1 | CC chemokine receptor antagonist | 0.1 0.035 DBMET02153 | ||
| 0.233 | 0.169 | 0.488 | Histamine release inhibitor | 0.233 0.169 DBMET02153 0.488 0.033 DBMET02164 | DBMET02164 | |
| 0.167 | 0.102 | 0.167 | I kappa B kinase epsilon inhibitor | 0.167 0.102 DBMET02153 | ||
| 0.108 | 0.045 | 0.13 | Glutamate (mGluR7) agonist | 0.108 0.045 DBMET02153 0.13 0.022 DBMET02164 | DBMET02164 | |
| 0.104 | 0.041 | 0.104 | Polo-like kinase-1 inhibitor | 0.101 0.045 DBMET02152 0.104 0.041 DBMET02153 | ||
| 0.168 | 0.105 | 0.168 | Growth factor agonist | 0.168 0.105 DBMET02153 | ||
| 0.122 | 0.059 | 0.122 | 5 Hydroxytryptamine 2B antagonist | 0.097 0.087 DBMET02152 0.122 0.059 DBMET02153 | ||
| 0.133 | 0.072 | 0.387 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.115 0.087 DBMET02152 0.133 0.072 DBMET02153 0.387 0.008 DBMET02150 | DBMET02150 | |
| 0.176 | 0.115 | 0.176 | Potassium channel (Voltage-sensitive) blocker | 0.176 0.115 DBMET02153 0.159 0.13 DBMET02150 | ||
| 0.145 | 0.085 | 0.155 | CF transmembrane conductance regulator agonist | 0.134 0.109 DBMET02152 0.145 0.085 DBMET02153 0.155 0.067 DBMET02164 | DBMET02164 | |
| 0.142 | 0.082 | 0.142 | Acetylcholine M1 receptor antagonist | 0.142 0.082 DBMET02153 | ||
| 0.093 | 0.035 | 0.101 | Dopamine D2 antagonist | 0.101 0.032 DBMET02152 0.093 0.035 DBMET02153 | DBMET02152 | |
| 0.206 | 0.148 | 0.346 | Insulysin inhibitor | 0.212 0.14 DBMET02152 0.206 0.148 DBMET02153 0.346 0.035 DBMET02164 | DBMET02164 | |
| 0.109 | 0.051 | 0.12 | Sphingomyelinase inhibitor | 0.094 0.066 DBMET02152 0.109 0.051 DBMET02153 0.12 0.041 DBMET02164 | DBMET02164 | |
| 0.122 | 0.064 | 0.122 | 5 Hydroxytryptamine antagonist | 0.122 0.064 DBMET02153 | ||
| 0.073 | 0.016 | 0.083 | Epithelial sodium channel blocker | 0.056 0.035 DBMET02152 0.073 0.016 DBMET02153 0.083 0.011 DBMET02164 | DBMET02164 | |
| 0.091 | 0.034 | 0.091 | Ca(v)3.1 blocker | 0.085 0.048 DBMET02152 0.091 0.034 DBMET02153 | ||
| 0.109 | 0.052 | 0.109 | Alpha adrenoreceptor antagonist | 0.109 0.052 DBMET02153 | ||
| 0.111 | 0.054 | 0.111 | Chemokine receptor antagonist | 0.111 0.054 DBMET02153 | ||
| 0.099 | 0.044 | 0.099 | Alpha 1 adrenoreceptor antagonist | 0.099 0.044 DBMET02153 | ||
| 0.065 | 0.009 | 0.065 | Potassium channel subfamily K member 3 blocker | 0.028 0.025 DBMET02152 0.065 0.009 DBMET02153 0.029 0.024 DBMET02150 | ||
| 0.126 | 0.071 | 0.298 | MAO inhibitor | 0.146 0.062 DBMET02152 0.126 0.071 DBMET02153 0.298 0.02 DBMET02150 0.246 0.029 DBMET02151 | DBMET02150 | |
| 0.061 | 0.007 | 0.061 | Delayed rectifier potassium channel blocker | 0.034 0.033 DBMET02152 0.061 0.007 DBMET02153 0.037 0.026 DBMET02164 | ||
| 0.083 | 0.029 | 0.083 | Bcl2 antagonist | 0.065 0.048 DBMET02152 0.083 0.029 DBMET02153 | ||
| 0.183 | 0.131 | 0.183 | DNA damaging | 0.183 0.131 DBMET02153 0.178 0.136 DBMET02164 0.163 0.154 DBMET02151 | ||
| 0.079 | 0.027 | 0.079 | Exportin-1 inhibitor | 0.079 0.027 DBMET02153 0.079 0.026 DBMET02164 | ||
| 0.122 | 0.072 | 0.122 | MAP kinase kinase inhibitor | 0.101 0.094 DBMET02152 0.122 0.072 DBMET02153 | ||
| 0.097 | 0.047 | 0.097 | 5 Hydroxytryptamine 2C antagonist | 0.097 0.047 DBMET02153 | ||
| 0.122 | 0.072 | 0.13 | Nav1.3 sodium channel blocker | 0.122 0.072 DBMET02153 0.13 0.064 DBMET02164 | DBMET02164 | |
| 0.069 | 0.02 | 0.069 | Bombesin 2 receptor antagonist | 0.053 0.029 DBMET02152 0.069 0.02 DBMET02153 0.063 0.022 DBMET02164 | ||
| 0.135 | 0.089 | 0.324 | Diuretic | 0.114 0.112 DBMET02152 0.135 0.089 DBMET02153 0.324 0.019 DBMET02164 | DBMET02164 | |
| 0.073 | 0.027 | 0.073 | 5 Hydroxytryptamine 3 antagonist | 0.073 0.027 DBMET02153 | ||
| 0.066 | 0.022 | 0.277 | Phosphorylase inhibitor | 0.042 0.036 DBMET02152 0.066 0.022 DBMET02153 0.277 0.004 DBMET02164 | DBMET02164 | |
| 0.064 | 0.021 | 0.064 | Potassium channel (Inward rectifier) blocker | 0.064 0.021 DBMET02153 | ||
| 0.068 | 0.024 | 0.084 | Beta 2 adrenoreceptor agonist | 0.084 0.007 DBMET02152 0.068 0.024 DBMET02153 0.065 0.031 DBMET02164 | DBMET02152 | |
| 0.047 | 0.004 | 0.047 | 5 Hydroxytryptamine 4 agonist | 0.029 0.008 DBMET02152 0.047 0.004 DBMET02153 0.034 0.005 DBMET02150 0.023 0.022 DBMET02151 | ||
| 0.099 | 0.056 | 0.099 | Antihistaminic | 0.099 0.056 DBMET02153 | ||
| 0.108 | 0.065 | 0.108 | Protein kinase C gamma inhibitor | 0.108 0.065 DBMET02153 | ||
| 0.108 | 0.066 | 0.225 | GABA C receptor antagonist | 0.108 0.066 DBMET02153 0.225 0.009 DBMET02164 | DBMET02164 | |
| 0.085 | 0.043 | 0.085 | Alpha 1a adrenoreceptor antagonist | 0.085 0.043 DBMET02153 | ||
| 0.099 | 0.056 | 0.265 | Potassium channel (Ca-activated) activator | 0.089 0.065 DBMET02152 0.099 0.056 DBMET02153 0.265 0.007 DBMET02164 | DBMET02164 | |
| 0.16 | 0.118 | 0.198 | Anticonvulsant | 0.16 0.118 DBMET02153 0.198 0.084 DBMET02164 | DBMET02164 | |
| 0.071 | 0.029 | 0.071 | Cathepsin L inhibitor | 0.071 0.029 DBMET02153 0.051 0.05 DBMET02164 | ||
| 0.093 | 0.051 | 0.093 | 5 Hydroxytryptamine 2A antagonist | 0.093 0.051 DBMET02153 | ||
| 0.114 | 0.073 | 0.121 | Acetylcholine muscarinic antagonist | 0.121 0.066 DBMET02152 0.114 0.073 DBMET02153 | DBMET02152 | |
| 0.162 | 0.121 | 0.263 | Neurotrophic factor enhancer | 0.17 0.11 DBMET02152 0.162 0.121 DBMET02153 0.263 0.032 DBMET02164 | DBMET02164 | |
| 0.05 | 0.009 | 0.05 | ATM kinase inhibitor | 0.035 0.029 DBMET02152 0.05 0.009 DBMET02153 0.034 0.033 DBMET02150 | ||
| 0.045 | 0.004 | 0.058 | ICAM 1 antagonist | 0.028 0.008 DBMET02152 0.045 0.004 DBMET02153 0.058 0.004 DBMET02164 0.021 0.02 DBMET02150 | DBMET02164 | |
| 0.049 | 0.008 | 0.051 | Ceramide glucosyltransferase inhibitor | 0.045 0.011 DBMET02152 0.049 0.008 DBMET02153 0.051 0.006 DBMET02164 0.039 0.019 DBMET02151 | DBMET02164 | |
| 0.083 | 0.044 | 0.083 | Alpha 1b adrenoreceptor antagonist | 0.083 0.044 DBMET02153 | ||
| 0.088 | 0.049 | 0.088 | Histamine H1 receptor antagonist | 0.088 0.049 DBMET02153 | ||
| 0.1 | 0.061 | 0.212 | GABA C receptor rho-1 antagonist | 0.1 0.061 DBMET02153 0.212 0.006 DBMET02164 | DBMET02164 | |
| 0.179 | 0.141 | 0.179 | Cardiotonic | 0.179 0.141 DBMET02153 | ||
| 0.089 | 0.051 | 0.089 | ErbB-3 antagonist | 0.089 0.051 DBMET02153 | ||
| 0.086 | 0.048 | 0.086 | Caspase 7 inhibitor | 0.086 0.048 DBMET02153 0.076 0.072 DBMET02164 | ||
| 0.088 | 0.049 | 0.12 | D-Ala-D-Ala ligase inhibitor | 0.087 0.051 DBMET02152 0.088 0.049 DBMET02153 0.12 0.014 DBMET02164 | DBMET02164 | |
| 0.102 | 0.064 | 0.157 | Urease inhibitor | 0.12 0.045 DBMET02152 0.102 0.064 DBMET02153 0.157 0.02 DBMET02164 | DBMET02164 | |
| 0.234 | 0.197 | 0.273 | Alpha-glucosidase inhibitor | 0.273 0.174 DBMET02152 0.234 0.197 DBMET02153 | DBMET02152 | |
| 0.096 | 0.058 | 0.096 | Potassium channel (Voltage-sensitive) activator | 0.096 0.058 DBMET02153 | ||
| 0.095 | 0.059 | 0.095 | Antiadrenergic | 0.095 0.059 DBMET02153 | ||
| 0.086 | 0.05 | 0.132 | Estrogen-related receptor beta agonist | 0.098 0.027 DBMET02152 0.086 0.05 DBMET02153 0.132 0.006 DBMET02164 | DBMET02164 | |
| 0.089 | 0.053 | 0.089 | Bcr-Abl kinase inhibitor | 0.089 0.053 DBMET02153 | ||
| 0.061 | 0.026 | 0.076 | Alpha-mannosidase inhibitor | 0.055 0.035 DBMET02152 0.061 0.026 DBMET02153 0.076 0.013 DBMET02164 0.055 0.035 DBMET02151 | DBMET02164 | |
| 0.081 | 0.046 | 0.081 | 5 Hydroxytryptamine 1 antagonist | 0.081 0.046 DBMET02153 | ||
| 0.09 | 0.055 | 0.09 | Histamine antagonist | 0.09 0.055 DBMET02153 | ||
| 0.115 | 0.082 | 0.145 | Cathepsin H inhibitor | 0.115 0.082 DBMET02153 0.145 0.05 DBMET02164 | DBMET02164 | |
| 0.081 | 0.048 | 0.081 | Alpha 2a adrenoreceptor antagonist | 0.081 0.048 DBMET02153 | ||
| 0.069 | 0.035 | 0.069 | Alpha 1d adrenoreceptor antagonist | 0.069 0.035 DBMET02153 | ||
| 0.084 | 0.051 | 0.124 | T cell inhibitor | 0.08 0.065 DBMET02152 0.084 0.051 DBMET02153 0.124 0.013 DBMET02164 | DBMET02164 | |
| 0.091 | 0.059 | 0.091 | Adrenaline antagonist | 0.091 0.059 DBMET02153 | ||
| 0.074 | 0.044 | 0.074 | 5 Hydroxytryptamine 1A antagonist | 0.074 0.044 DBMET02153 | ||
| 0.05 | 0.02 | 0.05 | Glutamate (mGluR1a) antagonist | 0.05 0.02 DBMET02153 | ||
| 0.053 | 0.023 | 0.053 | Cytokine production stimulant | 0.053 0.023 DBMET02153 | ||
| 0.063 | 0.033 | 0.063 | Alpha 1 adrenoreceptor agonist | 0.063 0.033 DBMET02153 | ||
| 0.054 | 0.026 | 0.054 | Potassium channel Kv1.3 blocker | 0.044 0.036 DBMET02152 0.054 0.026 DBMET02153 0.042 0.039 DBMET02164 | ||
| 0.048 | 0.021 | 0.048 | Cathepsin L1 inhibitor | 0.048 0.021 DBMET02153 | ||
| 0.035 | 0.009 | 0.035 | Urotensin II antagonist | 0.033 0.009 DBMET02152 0.035 0.009 DBMET02153 | ||
| 0.084 | 0.058 | 0.084 | mTOR complex 2 inhibitor | 0.084 0.058 DBMET02153 | ||
| 0.04 | 0.014 | 0.1 | Tryptophan 5 hydroxylase inhibitor | 0.04 0.014 DBMET02153 0.1 0.002 DBMET02164 | DBMET02164 | |
| 0.085 | 0.06 | 0.085 | Stem cell growth factor agonist | 0.085 0.06 DBMET02153 | ||
| 0.061 | 0.037 | 0.061 | Ca(v)3.2 blocker | 0.061 0.037 DBMET02153 | ||
| 0.049 | 0.025 | 0.09 | Stearoyl-CoA desaturase inhibitor | 0.049 0.025 DBMET02153 0.09 0.009 DBMET02164 | DBMET02164 | |
| 0.027 | 0.004 | 0.05 | Integrin beta2 antagonist | 0.027 0.004 DBMET02153 0.05 0.003 DBMET02164 | DBMET02164 | |
| 0.058 | 0.036 | 0.058 | Acetylcholine muscarinic agonist | 0.058 0.036 DBMET02153 | ||
| 0.063 | 0.041 | 0.063 | Histone deacetylase SIRT3 inhibitor | 0.063 0.041 DBMET02153 | ||
| 0.135 | 0.114 | 0.135 | Antipruritic | 0.135 0.114 DBMET02153 0.132 0.12 DBMET02164 | ||
| 0.192 | 0.172 | 0.499 | Cholesterol antagonist | 0.192 0.172 DBMET02153 0.499 0.033 DBMET02164 | DBMET02164 | |
| 0.225 | 0.205 | 0.225 | Transcription factor inhibitor | 0.225 0.205 DBMET02153 | ||
| 0.082 | 0.063 | 0.082 | Alpha 2 adrenoreceptor antagonist | 0.082 0.063 DBMET02153 | ||
| 0.127 | 0.109 | 0.162 | Adenylate cyclase stimulant | 0.136 0.089 DBMET02152 0.127 0.109 DBMET02153 0.162 0.044 DBMET02164 | DBMET02164 | |
| 0.078 | 0.06 | 0.116 | Adrenaline agonist | 0.116 0.027 DBMET02152 0.078 0.06 DBMET02153 0.077 0.061 DBMET02164 | DBMET02152 | |
| 0.03 | 0.013 | 0.037 | CC chemokine 1 receptor antagonist | 0.037 0.01 DBMET02152 0.03 0.013 DBMET02153 0.022 0.019 DBMET02164 | DBMET02152 | |
| 0.066 | 0.049 | 0.066 | Alpha adrenoreceptor agonist | 0.066 0.049 DBMET02153 | ||
| 0.079 | 0.063 | 0.198 | Glutathione S-transferase inhibitor | 0.079 0.063 DBMET02153 0.198 0.005 DBMET02164 | DBMET02164 | |
| 0.052 | 0.036 | 0.052 | Phosphodiesterase 7A inhibitor | 0.052 0.036 DBMET02153 | ||
| 0.044 | 0.029 | 0.044 | Acetylcholine M1 receptor agonist | 0.044 0.029 DBMET02153 | ||
| 0.036 | 0.02 | 0.037 | Sirtuin 2 inhibitor | 0.036 0.02 DBMET02153 0.037 0.019 DBMET02164 | DBMET02164 | |
| 0.083 | 0.068 | 0.202 | NADH dehydrogenase inhibitor | 0.085 0.065 DBMET02152 0.083 0.068 DBMET02153 0.202 0.01 DBMET02164 | DBMET02164 | |
| 0.107 | 0.093 | 0.179 | Cyclooxygenase 3 inhibitor | 0.107 0.093 DBMET02153 0.179 0.028 DBMET02164 | DBMET02164 | |
| 0.117 | 0.103 | 0.16 | Sphingosine 1-phosphate receptor 2 antagonist | 0.116 0.106 DBMET02152 0.117 0.103 DBMET02153 0.16 0.03 DBMET02164 | DBMET02164 | |
| 0.106 | 0.093 | 0.414 | Alpha-N-acetylglucosaminidase inhibitor | 0.106 0.093 DBMET02153 0.414 0.008 DBMET02164 | DBMET02164 | |
| 0.091 | 0.078 | 0.091 | Nav1.1 sodium channel blocker | 0.091 0.078 DBMET02153 | ||
| 0.058 | 0.045 | 0.058 | Potassium channel intermediate-conductance Ca-activated blocker | 0.058 0.045 DBMET02153 | ||
| 0.083 | 0.07 | 0.084 | Potassium channel activator | 0.083 0.07 DBMET02153 0.084 0.069 DBMET02164 | DBMET02164 | |
| 0.082 | 0.071 | 0.082 | Falcipain inhibitor | 0.082 0.071 DBMET02153 | ||
| 0.053 | 0.042 | 0.053 | Sphingosine kinase 2 inhibitor | 0.053 0.042 DBMET02153 | ||
| 0.051 | 0.041 | 0.055 | Nicotinic alpha3beta2 receptor antagonist | 0.051 0.041 DBMET02153 0.055 0.033 DBMET02150 | DBMET02150 | |
| 0.037 | 0.026 | 0.101 | Integrin alpha2 antagonist | 0.037 0.026 DBMET02153 0.101 0.004 DBMET02164 | DBMET02164 | |
| 0.194 | 0.184 | 0.441 | Antithrombotic | 0.194 0.184 DBMET02153 0.441 0.04 DBMET02164 | DBMET02164 | |
| 0.051 | 0.041 | 0.051 | Nicotinic alpha7 receptor agonist | 0.051 0.041 DBMET02153 | ||
| 0.029 | 0.02 | 0.029 | MAP3K8 inhibitor | 0.029 0.02 DBMET02153 | ||
| 0.021 | 0.012 | 0.03 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.021 0.012 DBMET02153 0.03 0.004 DBMET02150 0.026 0.005 DBMET02151 | DBMET02150 | |
| 0.066 | 0.057 | 0.066 | Protein kinase C beta inhibitor | 0.066 0.057 DBMET02153 | ||
| 0.032 | 0.023 | 0.032 | Vanilloid 4 antagonist | 0.032 0.023 DBMET02153 | ||
| 0.068 | 0.059 | 0.108 | Glycine receptor agonist | 0.068 0.059 DBMET02153 0.108 0.017 DBMET02164 | DBMET02164 | |
| 0.13 | 0.122 | 0.153 | Ca2+-transporting ATPase inhibitor | 0.13 0.122 DBMET02153 0.153 0.036 DBMET02164 | DBMET02164 | |
| 0.219 | 0.211 | 0.219 | DNA polymerase beta inhibitor | 0.219 0.211 DBMET02153 0.215 0.213 DBMET02164 | ||
| 0.105 | 0.098 | 0.105 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.105 0.098 DBMET02153 | ||
| 0.028 | 0.021 | 0.028 | Nicotinamide phosphoribosyltransferase inhibitor | 0.028 0.021 DBMET02153 | ||
| 0.137 | 0.131 | 0.137 | Cyclin-dependent kinase 3 inhibitor | 0.137 0.131 DBMET02153 | ||
| 0.073 | 0.067 | 0.073 | Viral attachment inhibitor | 0.073 0.067 DBMET02153 | ||
| 0.049 | 0.043 | 0.049 | Toll-Like receptor 8 antagonist | 0.049 0.043 DBMET02153 | ||
| 0.089 | 0.083 | 0.089 | Mediator release inhibitor | 0.089 0.083 DBMET02153 | ||
| 0.054 | 0.049 | 0.074 | Acetylcholine M3 receptor antagonist | 0.074 0.029 DBMET02152 0.054 0.049 DBMET02153 | DBMET02152 | |
| 0.099 | 0.094 | 0.099 | Interleukin 2 antagonist | 0.099 0.094 DBMET02153 | ||
| 0.08 | 0.075 | 0.094 | MAO B inhibitor | 0.094 0.063 DBMET02152 0.08 0.075 DBMET02153 | DBMET02152 | |
| 0.029 | 0.025 | 0.032 | Epoxide hydrolase 1 inhibitor | 0.029 0.025 DBMET02153 0.032 0.02 DBMET02164 | DBMET02164 | |
| 0.076 | 0.072 | 0.076 | Histamine N-methyltransferase inhibitor | 0.076 0.072 DBMET02153 | ||
| 0.077 | 0.073 | 0.077 | Falcipain 2 inhibitor | 0.077 0.073 DBMET02153 | ||
| 0.094 | 0.09 | 0.094 | Multidrug resistance-associated protein 1 inhibitor | 0.094 0.09 DBMET02153 | ||
| 0.047 | 0.042 | 0.047 | Sodium/calcium exchanger inhibitor | 0.047 0.042 DBMET02153 | ||
| 0.061 | 0.057 | 0.061 | Nav1.7 sodium channel blocker | 0.061 0.057 DBMET02153 | ||
| 0.175 | 0.172 | 0.226 | Transcription factor STAT3 inhibitor | 0.175 0.172 DBMET02153 0.226 0.105 DBMET02164 | DBMET02164 | |
| 0.041 | 0.038 | 0.061 | Mannosidase inhibitor | 0.041 0.038 DBMET02153 0.061 0.016 DBMET02164 | DBMET02164 | |
| 0.005 | 0.003 | 0.005 | Reverse transcriptase (HBV) inhibitor | 0.005 0.003 DBMET02153 | ||
| 0.035 | 0.033 | 0.035 | Vascular adhesion protein 1 inhibitor | 0.035 0.033 DBMET02153 | ||
| 0.12 | 0.118 | 0.12 | Cyclin-dependent kinase 8 inhibitor | 0.12 0.118 DBMET02153 | ||
| 0.075 | 0.074 | 0.075 | Acetylcholine agonist | 0.075 0.074 DBMET02153 | ||
| 0.031 | 0.031 | 0.06 | p53 inhibitor | 0.06 0.009 DBMET02164 | DBMET02164 | |
| 0.055 | 0.056 | 0.098 | Dopamine D1 antagonist | 0.098 0.025 DBMET02152 | DBMET02152 | |
| 0.01 | 0.011 | 0.076 | Egl nine homolog 3 inhibitor | 0.076 0.002 DBMET02164 | DBMET02164 | |
| 0.115 | 0.116 | 0.154 | Farnesoid X receptor antagonist | 0.137 0.07 DBMET02152 0.154 0.047 DBMET02164 | DBMET02164 | |
| 0.043 | 0.045 | 0.052 | Potassium channel (ATP-sensitive) activator | 0.052 0.026 DBMET02164 | DBMET02164 | |
| 0.045 | 0.047 | 0.054 | Potassium channel (Inward rectifier) activator | 0.054 0.028 DBMET02164 | DBMET02164 | |
| 0.08 | 0.081 | 0.107 | Protein kinase C mu inhibitor | 0.107 0.051 DBMET02151 | DBMET02151 | |
| 0.139 | 0.142 | 0.145 | HERG channel blocker | 0.145 0.136 DBMET02150 | DBMET02150 | |
| 0.005 | 0.009 | 0.007 | Integrin alpha5beta6 antagonist | 0.007 0.004 DBMET02164 | DBMET02164 | |
| 0.033 | 0.037 | 0.039 | DNA gyrase subunit B inhibitor | 0.039 0.025 DBMET02164 | DBMET02164 | |
| 0.117 | 0.123 | 0.128 | Death-associated protein kinase 1 inhibitor | 0.128 0.088 DBMET02152 | DBMET02152 | |
| 0.048 | 0.054 | 0.091 | Prostaglandin EP2 antagonist | 0.091 0.022 DBMET02164 | DBMET02164 | |
| 0.131 | 0.137 | 0.222 | DNA methylase inhibitor | 0.15 0.117 DBMET02152 0.222 0.065 DBMET02164 | DBMET02164 | |
| 0.035 | 0.041 | 0.084 | Glucagon-like peptide 1 receptor antagonist | 0.084 0.005 DBMET02164 | DBMET02164 | |
| 0.086 | 0.093 | 0.142 | AMP-activated protein kinase stimulant | 0.089 0.087 DBMET02152 0.142 0.033 DBMET02164 | DBMET02164 | |
| 0.009 | 0.019 | 0.02 | Integrin alphaLbeta2 antagonist | 0.02 0.005 DBMET02164 | DBMET02164 | |
| 0.042 | 0.052 | 0.049 | CC chemokine receptor 2B antagonist | 0.049 0.034 DBMET02164 | DBMET02164 | |
| 0.201 | 0.212 | 0.272 | Calcium channel activator | 0.272 0.122 DBMET02164 | DBMET02164 | |
| 0.027 | 0.038 | 0.044 | Carnitine palmitoyltransferase inhibitor | 0.044 0.012 DBMET02164 | DBMET02164 | |
| 0.027 | 0.039 | 0.043 | Carnitine palmitoyltransferase 1 inhibitor | 0.043 0.013 DBMET02164 | DBMET02164 | |
| 0.034 | 0.046 | 0.053 | Integrin alpha1beta1 antagonist | 0.053 0.006 DBMET02164 | DBMET02164 | |
| 0.046 | 0.06 | 0.089 | Thromboxane synthase inhibitor | 0.089 0.009 DBMET02164 | DBMET02164 | |
| 0.029 | 0.044 | 0.057 | Dopamine D5 antagonist | 0.057 0.021 DBMET02152 | DBMET02152 | |
| 0.081 | 0.097 | 0.121 | Bile acid receptor antagonist | 0.121 0.019 DBMET02164 | DBMET02164 | |
| 0.126 | 0.142 | 0.173 | Anesthetic general | 0.173 0.092 DBMET02164 | DBMET02164 | |
| 0.038 | 0.054 | 0.044 | Heme oxygenase inhibitor | 0.044 0.027 DBMET02164 | DBMET02164 | |
| 0.023 | 0.039 | 0.033 | Purinergic P2Y15 antagonist | 0.033 0.012 DBMET02164 | DBMET02164 | |
| 0.085 | 0.101 | 0.279 | Chelator | 0.123 0.051 DBMET02152 0.279 0.013 DBMET02164 | DBMET02164 | |
| 0.066 | 0.083 | 0.131 | GABA B receptor agonist | 0.072 0.062 DBMET02152 0.131 0.005 DBMET02164 | DBMET02164 | |
| 0.008 | 0.026 | 0.016 | Microsomal triglyceride transfer protein inhibitor | 0.016 0.01 DBMET02150 | DBMET02150 | |
| 0.056 | 0.075 | 0.075 | Amidase inhibitor | 0.075 0.042 DBMET02164 | DBMET02164 | |
| 0.04 | 0.059 | 0.047 | Beta adrenoreceptor agonist | 0.047 0.024 DBMET02152 0.045 0.033 DBMET02164 | DBMET02152 | |
| 0.008 | 0.028 | 0.086 | Egl nine homolog 1 inhibitor | 0.086 0.003 DBMET02164 | DBMET02164 | |
| 0.008 | 0.029 | 0.017 | Integrin alphaVbeta6 antagonist | 0.017 0.007 DBMET02164 | DBMET02164 | |
| 0.02 | 0.04 | 0.05 | Integrin alpha2beta1 antagonist | 0.05 0.004 DBMET02164 | DBMET02164 | |
| 0.019 | 0.04 | 0.419 | Protocollagen prolyl hydroxylase inhibitor | 0.419 0.002 DBMET02164 | DBMET02164 | |
| 0.031 | 0.053 | 0.058 | Carbonic anhydrase VII inhibitor | 0.058 0.02 DBMET02164 | DBMET02164 | |
| 0.035 | 0.057 | 0.044 | Metalloproteinase-3 inhibitor | 0.044 0.041 DBMET02164 | DBMET02164 | |
| 0.011 | 0.033 | 0.019 | Integrin beta6 antagonist | 0.019 0.005 DBMET02164 | DBMET02164 | |
| 0.037 | 0.06 | 0.067 | Carnitine palmitoyltransferase 1B inhibitor | 0.067 0.012 DBMET02164 | DBMET02164 | |
| 0.206 | 0.229 | 0.54 | Analgesic | 0.498 0.05 DBMET02150 0.54 0.039 DBMET02151 | DBMET02151 | |
| 0.117 | 0.141 | 0.132 | Pregnane X receptor agonist | 0.132 0.093 DBMET02164 | DBMET02164 | |
| 0.084 | 0.108 | 0.179 | Folate antagonist | 0.179 0.014 DBMET02164 | DBMET02164 | |
| 0.054 | 0.078 | 0.135 | Potassium channel large-conductance Ca-activated activator | 0.135 0.013 DBMET02164 | DBMET02164 | |
| 0.013 | 0.038 | 0.022 | Estrogen-related receptor gamma agonist | 0.022 0.008 DBMET02164 | DBMET02164 | |
| 0.028 | 0.053 | 0.041 | Factor Xa inhibitor | 0.041 0.036 DBMET02164 | DBMET02164 | |
| 0.005 | 0.03 | 0.008 | Free fatty acid receptor 2 antagonist | 0.008 0.007 DBMET02164 | DBMET02164 | |
| 0.037 | 0.064 | 0.1 | Diacylglycerol O-acyltransferase inhibitor | 0.1 0.007 DBMET02164 | DBMET02164 | |
| 0.034 | 0.062 | 0.04 | CF transmembrane conductance regulator antagonist | 0.04 0.026 DBMET02152 0.039 0.031 DBMET02164 | DBMET02152 | |
| 0.033 | 0.061 | 0.05 | VCAM-1 antagonist | 0.05 0.009 DBMET02164 | DBMET02164 | |
| 0.103 | 0.131 | 0.192 | Cell wall synthesis inhibitor | 0.192 0.033 DBMET02164 | DBMET02164 | |
| 0.033 | 0.061 | 0.05 | VCAM antagonist | 0.05 0.009 DBMET02164 | DBMET02164 | |
| 0.081 | 0.11 | 0.128 | c-Src kinase inhibitor | 0.128 0.069 DBMET02152 | DBMET02152 | |
| 0.022 | 0.052 | 0.034 | Phosphoglycerate kinase inhibitor | 0.034 0.026 DBMET02152 0.032 0.028 DBMET02164 | DBMET02152 | |
| 0.041 | 0.073 | 0.16 | NMDA receptor glycine site agonist | 0.16 0.004 DBMET02164 | DBMET02164 | |
| 0.073 | 0.107 | 0.082 | Protein kinase C zeta inhibitor | 0.082 0.081 DBMET02152 | DBMET02152 | |
| 0.007 | 0.041 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DBMET02164 | DBMET02164 | |
| 0.095 | 0.129 | 0.145 | Histone deacetylase SIRT1 inhibitor | 0.145 0.066 DBMET02164 | DBMET02164 | |
| 0.02 | 0.055 | 0.029 | Methionyl aminopeptidase 1 inhibitor | 0.029 0.028 DBMET02164 | DBMET02164 | |
| 0.029 | 0.067 | 0.045 | Thymidine kinase inhibitor | 0.045 0.024 DBMET02164 | DBMET02164 | |
| 0.08 | 0.118 | 0.107 | Alkylator | 0.107 0.081 DBMET02164 | DBMET02164 | |
| 0.012 | 0.051 | 0.023 | Tryptophan hydroxylase 1 inhibitor | 0.023 0.005 DBMET02164 | DBMET02164 | |
| 0.154 | 0.196 | 0.258 | DNA synthesis inhibitor | 0.176 0.16 DBMET02152 0.258 0.062 DBMET02164 0.211 0.107 DBMET02151 | DBMET02164 | |
| 0.16 | 0.203 | 0.243 | Hypoxia-inducible factor 1 alpha inhibitor | 0.18 0.179 DBMET02152 0.243 0.107 DBMET02164 | DBMET02164 | |
| 0.032 | 0.076 | 0.048 | Glutamate (mGluR4) antagonist | 0.048 0.023 DBMET02164 | DBMET02164 | |
| 0.012 | 0.057 | 0.051 | Glycine transporter 1 inhibitor | 0.051 0.015 DBMET02164 | DBMET02164 | |
| 0.123 | 0.168 | 0.142 | Heat shock protein 70 antagonist | 0.142 0.068 DBMET02164 | DBMET02164 | |
| 0.009 | 0.055 | 0.039 | Prostaglandin H2 antagonist | 0.039 0.006 DBMET02164 | DBMET02164 | |
| 0.049 | 0.096 | 0.586 | Telomerase inhibitor | 0.586 0.004 DBMET02150 0.328 0.005 DBMET02151 | DBMET02150 | |
| 0.028 | 0.075 | 0.085 | Carbonic anhydrase I inhibitor | 0.085 0.023 DBMET02164 | DBMET02164 | |
| 0.046 | 0.094 | 0.058 | Protease 3C (Human rhinovirus) inhibitor | 0.058 0.056 DBMET02164 | DBMET02164 | |
| 0.064 | 0.112 | 0.073 | MAP kinase kinase 7 inhibitor | 0.073 0.069 DBMET02164 | DBMET02164 | |
| 0.077 | 0.126 | 0.18 | mTOR complex 1 inhibitor | 0.18 0.007 DBMET02151 | DBMET02151 | |
| 0.038 | 0.087 | 0.065 | Carbonic anhydrase stimulant | 0.065 0.036 DBMET02164 | DBMET02164 | |
| 0.066 | 0.115 | 0.267 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.267 0.008 DBMET02164 | DBMET02164 | |
| 0.012 | 0.061 | 0.031 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.031 0.017 DBMET02164 | DBMET02164 | |
| 0.092 | 0.142 | 0.118 | Src kinase inhibitor | 0.118 0.11 DBMET02152 | DBMET02152 | |
| 0.013 | 0.062 | 0.199 | Glucagon receptor antagonist | 0.199 0.003 DBMET02164 | DBMET02164 | |
| 0.049 | 0.099 | 0.068 | Topoisomerase II alpha inhibitor | 0.068 0.063 DBMET02164 | DBMET02164 | |
| 0.023 | 0.074 | 0.396 | Erythropoietin receptor agonist | 0.396 0.004 DBMET02164 | DBMET02164 | |
| 0.149 | 0.201 | 0.18 | RNA-directed DNA polymerase inhibitor | 0.18 0.132 DBMET02164 | DBMET02164 | |
| 0.038 | 0.091 | 0.056 | Factor III inhibitor | 0.056 0.023 DBMET02164 | DBMET02164 | |
| 0.047 | 0.1 | 0.14 | Cathepsin G inhibitor | 0.14 0.023 DBMET02164 | DBMET02164 | |
| 0.013 | 0.067 | 0.094 | Lysine carboxypeptidase inhibitor | 0.094 0.004 DBMET02164 | DBMET02164 | |
| 0.033 | 0.088 | 0.053 | Prolyl endopeptidase inhibitor | 0.053 0.032 DBMET02164 | DBMET02164 | |
| 0.005 | 0.063 | 0.038 | Integrin alpha4beta7 antagonist | 0.038 0.007 DBMET02164 | DBMET02164 | |
| 0.034 | 0.092 | 0.053 | Topoisomerase II beta inhibitor | 0.053 0.029 DBMET02164 | DBMET02164 | |
| 0.103 | 0.161 | 0.226 | Hemostatic | 0.226 0.025 DBMET02164 | DBMET02164 | |
| 0.01 | 0.069 | 0.025 | Integrin alphaVbeta1 antagonist | 0.025 0.008 DBMET02164 | DBMET02164 | |
| 0.004 | 0.064 | 0.041 | Integrin alpha4beta1 antagonist | 0.041 0.006 DBMET02164 | DBMET02164 | |
| 0.08 | 0.141 | 0.136 | CDK3/cyclin E inhibitor | 0.136 0.037 DBMET02164 | DBMET02164 | |
| 0.006 | 0.068 | 0.029 | Integrin beta7 antagonist | 0.029 0.01 DBMET02164 | DBMET02164 | |
| 0.051 | 0.114 | 0.068 | Metalloproteinase-9 inhibitor | 0.068 0.06 DBMET02164 | DBMET02164 | |
| 0.079 | 0.142 | 0.143 | TRPA1 agonist | 0.143 0.036 DBMET02164 | DBMET02164 | |
| 0.05 | 0.113 | 0.145 | GABA aminotransferase inhibitor | 0.145 0.009 DBMET02164 | DBMET02164 | |
| 0.05 | 0.113 | 0.094 | Metalloproteinase-2 inhibitor | 0.094 0.041 DBMET02164 | DBMET02164 | |
| 0.043 | 0.107 | 0.063 | Corticotropin releasing factor 2 receptor antagonist | 0.063 0.04 DBMET02164 | DBMET02164 | |
| 0.041 | 0.104 | 0.219 | NMDA receptor agonist | 0.219 0.004 DBMET02164 | DBMET02164 | |
| 0.026 | 0.09 | 0.056 | Prostaglandin E2 antagonist | 0.056 0.031 DBMET02164 | DBMET02164 | |
| 0.071 | 0.135 | 0.106 | Glutamate release inhibitor | 0.106 0.034 DBMET02164 | DBMET02164 | |
| 0.105 | 0.17 | 0.141 | Dual specificity phosphatase inhibitor | 0.141 0.105 DBMET02152 | DBMET02152 | |
| 0.105 | 0.17 | 0.221 | DNA methyltransferase I inhibitor | 0.221 0.059 DBMET02164 | DBMET02164 | |
| 0.021 | 0.088 | 0.088 | Substance P antagonist | 0.088 0.007 DBMET02150 0.05 0.016 DBMET02151 | DBMET02150 | |
| 0.023 | 0.092 | 0.103 | Thymidylate synthase inhibitor | 0.103 0.004 DBMET02164 | DBMET02164 | |
| 0.027 | 0.096 | 0.061 | Neurokinin antagonist | 0.061 0.024 DBMET02150 0.052 0.032 DBMET02151 | DBMET02150 | |
| 0.019 | 0.089 | 0.033 | Factor XIIIa inhibitor | 0.033 0.031 DBMET02164 | DBMET02164 | |
| 0.032 | 0.102 | 0.091 | Carbamoyl phosphate synthetase inhibitor | 0.091 0.023 DBMET02164 | DBMET02164 | |
| 0.021 | 0.095 | 0.075 | Carbonic anhydrase II inhibitor | 0.075 0.027 DBMET02164 | DBMET02164 | |
| 0.006 | 0.081 | 0.024 | Thromboxane A2 agonist | 0.024 0.004 DBMET02164 | DBMET02164 | |
| 0.067 | 0.143 | 0.191 | Cholesterol synthesis inhibitor | 0.191 0.029 DBMET02164 | DBMET02164 | |
| 0.138 | 0.214 | 0.215 | Prostaglandin dehydrogenase inhibitor | 0.215 0.148 DBMET02152 | DBMET02152 | |
| 0.008 | 0.085 | 0.05 | Arginase inhibitor | 0.05 0.015 DBMET02164 | DBMET02164 | |
| 0.02 | 0.097 | 0.06 | Integrin alpha5beta1 antagonist | 0.06 0.012 DBMET02164 | DBMET02164 | |
| 0.018 | 0.096 | 0.031 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.031 0.029 DBMET02164 | DBMET02164 | |
| 0.093 | 0.174 | 0.134 | Dual specificity phosphatase 3 inhibitor | 0.134 0.111 DBMET02152 | DBMET02152 | |
| 0.009 | 0.091 | 0.033 | Kynurenine 3 monooxygenase inhibitor | 0.033 0.013 DBMET02164 | DBMET02164 | |
| 0.025 | 0.109 | 0.08 | Acyl-CoA dehydrogenase inhibitor | 0.08 0.022 DBMET02164 | DBMET02164 | |
| 0.013 | 0.097 | 0.095 | Carbonic anhydrase IV inhibitor | 0.095 0.008 DBMET02164 | DBMET02164 | |
| 0.014 | 0.098 | 0.028 | Peptide deformylase inhibitor | 0.028 0.024 DBMET02164 | DBMET02164 | |
| 0.032 | 0.117 | 0.072 | Sphingosine 1-phosphate receptor 3 antagonist | 0.072 0.023 DBMET02164 | DBMET02164 | |
| 0.042 | 0.128 | 0.066 | Leukotriene C antagonist | 0.066 0.019 DBMET02164 | DBMET02164 | |
| 0.027 | 0.113 | 0.049 | Beta 1 adrenoreceptor antagonist | 0.049 0.048 DBMET02164 | DBMET02164 | |
| 0.035 | 0.122 | 0.201 | Catalase inhibitor | 0.201 0.015 DBMET02164 | DBMET02164 | |
| 0.018 | 0.106 | 0.149 | NMDA 2A receptor antagonist | 0.149 0.007 DBMET02164 | DBMET02164 | |
| 0.035 | 0.124 | 0.079 | Sphingosine 1-phosphate receptor 5 agonist | 0.079 0.013 DBMET02164 | DBMET02164 | |
| 0.066 | 0.155 | 0.183 | Mucolytic | 0.183 0.018 DBMET02164 | DBMET02164 | |
| 0.037 | 0.126 | 0.065 | Beta adrenoreceptor antagonist | 0.065 0.046 DBMET02164 | DBMET02164 | |
| 0.007 | 0.097 | 0.015 | Vitamin D receptor agonist | 0.015 0.014 DBMET02164 | DBMET02164 | |
| 0.024 | 0.115 | 0.073 | AICAR transformylase inhibitor | 0.073 0.009 DBMET02164 | DBMET02164 | |
| 0.01 | 0.102 | 0.022 | Caspase 8 inhibitor | 0.022 0.01 DBMET02164 | DBMET02164 | |
| 0.023 | 0.114 | 0.088 | Carbonic anhydrase inhibitor | 0.088 0.031 DBMET02164 | DBMET02164 | |
| 0.114 | 0.206 | 0.299 | Phospholipase C inhibitor | 0.299 0.018 DBMET02164 | DBMET02164 | |
| 0.043 | 0.137 | 0.06 | Beta 3 adrenoreceptor antagonist | 0.06 0.054 DBMET02164 | DBMET02164 | |
| 0.057 | 0.151 | 0.111 | UDP-glucose 4-epimerase inhibitor | 0.111 0.05 DBMET02164 | DBMET02164 | |
| 0.063 | 0.158 | 0.112 | Histone deacetylase class III inhibitor | 0.112 0.077 DBMET02164 | DBMET02164 | |
| 0.02 | 0.116 | 0.038 | Leukocyte elastase inhibitor | 0.038 0.036 DBMET02164 | DBMET02164 | |
| 0.033 | 0.129 | 0.231 | CD45 antagonist | 0.231 0.004 DBMET02164 | DBMET02164 | |
| 0.047 | 0.145 | 0.128 | Glycine receptor antagonist | 0.128 0.014 DBMET02164 | DBMET02164 | |
| 0.016 | 0.115 | 0.038 | Toll-Like receptor 2 agonist | 0.038 0.032 DBMET02164 | DBMET02164 | |
| 0.018 | 0.117 | 0.066 | RNA-directed RNA polymerase inhibitor | 0.066 0.008 DBMET02164 | DBMET02164 | |
| 0.056 | 0.157 | 0.344 | GABA C receptor agonist | 0.344 0.007 DBMET02164 | DBMET02164 | |
| 0.103 | 0.206 | 0.221 | Non-steroidal antiinflammatory agent | 0.221 0.056 DBMET02164 | DBMET02164 | |
| 0.05 | 0.156 | 0.174 | Cell adhesion molecule inhibitor | 0.174 0.012 DBMET02164 | DBMET02164 | |
| 0.124 | 0.231 | 0.205 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.205 0.068 DBMET02164 | DBMET02164 | |
| 0.037 | 0.143 | 0.142 | Aminopeptidase I inhibitor | 0.142 0.014 DBMET02164 | DBMET02164 | |
| 0.03 | 0.138 | 0.203 | Sphingosine 1-phosphate receptor 4 agonist | 0.203 0.004 DBMET02164 | DBMET02164 | |
| 0.017 | 0.126 | 0.048 | Neurokinin 1 antagonist | 0.048 0.02 DBMET02150 0.044 0.024 DBMET02151 | DBMET02150 | |
| 0.012 | 0.123 | 0.131 | Integrin antagonist | 0.131 0.012 DBMET02164 | DBMET02164 | |
| 0.004 | 0.116 | 0.072 | VLA-4 antagonist | 0.072 0.009 DBMET02164 | DBMET02164 | |
| 0.006 | 0.118 | 0.022 | Prostaglandin EP2 agonist | 0.022 0.016 DBMET02164 | DBMET02164 | |
| 0.013 | 0.126 | 0.028 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.025 DBMET02164 | DBMET02164 | |
| 0.009 | 0.123 | 0.045 | HCV NS5B polymerase inhibitor | 0.045 0.011 DBMET02164 | DBMET02164 | |
| 0.049 | 0.164 | 0.248 | HIV-1 integrase (Overall Integration) inhibitor | 0.248 0.005 DBMET02164 | DBMET02164 | |
| 0.013 | 0.128 | 0.033 | Calcitonin receptor agonist | 0.033 0.024 DBMET02164 | DBMET02164 | |
| 0.012 | 0.127 | 0.045 | Farnesoid X receptor agonist | 0.045 0.018 DBMET02164 | DBMET02164 | |
| 0.008 | 0.124 | 0.051 | AMPA 3 receptor antagonist | 0.051 0.009 DBMET02164 | DBMET02164 | |
| 0.024 | 0.14 | 0.087 | Selectin antagonist | 0.087 0.033 DBMET02164 | DBMET02164 | |
| 0.077 | 0.194 | 0.265 | Anticoagulant | 0.265 0.035 DBMET02164 | DBMET02164 | |
| 0.053 | 0.17 | 0.154 | Triose-phosphate isomerase inhibitor | 0.154 0.019 DBMET02164 | DBMET02164 | |
| 0.009 | 0.127 | 0.032 | Prostaglandin EP4 antagonist | 0.032 0.014 DBMET02164 | DBMET02164 | |
| 0.028 | 0.147 | 0.048 | Factor IXa inhibitor | 0.048 0.041 DBMET02164 | DBMET02164 | |
| 0.082 | 0.202 | 0.196 | Arachidonic acid antagonist | 0.196 0.037 DBMET02164 | DBMET02164 | |
| 0.071 | 0.19 | 0.247 | Cell adhesion inhibitor | 0.247 0.015 DBMET02164 | DBMET02164 | |
| 0.099 | 0.221 | 0.3 | Immunostimulant | 0.3 0.078 DBMET02164 | DBMET02164 | |
| 0.019 | 0.141 | 0.088 | Thromboxane antagonist | 0.088 0.016 DBMET02164 | DBMET02164 | |
| 0.062 | 0.185 | 0.118 | Microtubule formation inhibitor | 0.118 0.063 DBMET02164 | DBMET02164 | |
| 0.008 | 0.13 | 0.032 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.032 0.018 DBMET02164 | DBMET02164 | |
| 0.004 | 0.127 | 0.073 | AMPA 1 receptor antagonist | 0.073 0.008 DBMET02164 | DBMET02164 | |
| 0.072 | 0.196 | 0.532 | Peroxidase inhibitor | 0.22 0.054 DBMET02152 0.532 0.007 DBMET02164 | DBMET02164 | |
| 0.017 | 0.141 | 0.079 | Thromboxane A2 antagonist | 0.079 0.015 DBMET02164 | DBMET02164 | |
| 0.004 | 0.128 | 0.03 | Egl nine homolog 2 inhibitor | 0.03 0.004 DBMET02164 | DBMET02164 | |
| 0.051 | 0.176 | 0.286 | Ferrochelatase inhibitor | 0.286 0.009 DBMET02164 | DBMET02164 | |
| 0.023 | 0.15 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.051 0.014 DBMET02164 | DBMET02164 | |
| 0.025 | 0.152 | 0.055 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.023 DBMET02164 | DBMET02164 | |
| 0.018 | 0.146 | 0.07 | Neutrophil collagenase inhibitor | 0.07 0.04 DBMET02164 | DBMET02164 | |
| 0.032 | 0.16 | 0.069 | Purinergic P2X1 antagonist | 0.069 0.033 DBMET02164 | DBMET02164 | |
| 0.039 | 0.167 | 0.072 | Macrophage migration inhibitory factor inhibitor | 0.072 0.062 DBMET02152 | DBMET02152 | |
| 0.039 | 0.17 | 0.085 | HIV-1 integrase inhibitor | 0.063 0.06 DBMET02152 0.085 0.035 DBMET02164 | DBMET02164 | |
| 0.034 | 0.164 | 0.092 | DNA helicase inhibitor | 0.092 0.007 DBMET02164 | DBMET02164 | |
| 0.007 | 0.138 | 0.028 | Glutamate (mGluR1a) agonist | 0.028 0.01 DBMET02164 | DBMET02164 | |
| 0.051 | 0.182 | 0.208 | Cystathionine beta-synthase inhibitor | 0.107 0.069 DBMET02152 0.208 0.023 DBMET02164 | DBMET02164 | |
| 0.147 | 0.279 | 0.303 | Antiobesity | 0.303 0.114 DBMET02164 | DBMET02164 | |
| 0.081 | 0.213 | 0.177 | Mannose-6-phosphate isomerase inhibitor | 0.177 0.044 DBMET02164 | DBMET02164 | |
| 0.004 | 0.137 | 0.055 | Integrin alpha4 antagonist | 0.055 0.01 DBMET02164 | DBMET02164 | |
| 0.023 | 0.156 | 0.103 | Biliverdin reductase inhibitor | 0.103 0.018 DBMET02164 | DBMET02164 | |
| 0.129 | 0.263 | 0.321 | Peptidyltransferase inhibitor | 0.321 0.018 DBMET02164 0.167 0.152 DBMET02151 | DBMET02164 | |
| 0.077 | 0.212 | 0.152 | Sphingosine 1-phosphate receptor 4 antagonist | 0.152 0.031 DBMET02164 | DBMET02164 | |
| 0.039 | 0.175 | 0.073 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.073 0.051 DBMET02164 | DBMET02164 | |
| 0.018 | 0.154 | 0.039 | AMPA 4 receptor antagonist | 0.039 0.028 DBMET02164 | DBMET02164 | |
| 0.023 | 0.162 | 0.052 | Kainate receptor agonist | 0.052 0.012 DBMET02164 | DBMET02164 | |
| 0.018 | 0.158 | 0.051 | Dihydrofolate reductase inhibitor | 0.051 0.018 DBMET02164 | DBMET02164 | |
| 0.006 | 0.149 | 0.024 | CXC chemokine 2 receptor antagonist | 0.024 0.021 DBMET02164 | DBMET02164 | |
| 0.008 | 0.152 | 0.052 | Complement C3a chemotactic receptor antagonist | 0.052 0.026 DBMET02164 | DBMET02164 | |
| 0.012 | 0.155 | 0.058 | Dihydropteroate synthase inhibitor | 0.058 0.012 DBMET02164 | DBMET02164 | |
| 0.024 | 0.168 | 0.043 | Leukotriene C4 antagonist | 0.043 0.019 DBMET02164 | DBMET02164 | |
| 0.006 | 0.15 | 0.055 | GP IIb/IIIa receptor antagonist | 0.055 0.03 DBMET02164 | DBMET02164 | |
| 0.092 | 0.237 | 0.258 | Antiamyloidogenic | 0.16 0.134 DBMET02164 0.258 0.068 DBMET02150 | DBMET02150 | |
| 0.008 | 0.155 | 0.031 | Peroxisome proliferator-activated receptor delta agonist | 0.031 0.026 DBMET02164 | DBMET02164 | |
| 0.037 | 0.184 | 0.154 | Glutamate dehydrogenase inhibitor | 0.154 0.015 DBMET02164 | DBMET02164 | |
| 0.024 | 0.171 | 0.054 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.054 0.047 DBMET02164 | DBMET02164 | |
| 0.083 | 0.23 | 0.141 | Vanilloid 1 agonist | 0.141 0.049 DBMET02164 | DBMET02164 | |
| 0.118 | 0.266 | 0.187 | 12-Lipoxygenase inhibitor | 0.177 0.176 DBMET02152 0.187 0.166 DBMET02164 | DBMET02164 | |
| 0.009 | 0.158 | 0.042 | Fumarate hydratase inhibitor | 0.042 0.017 DBMET02164 | DBMET02164 | |
| 0.041 | 0.19 | 0.085 | Glutamate (mGluR6) antagonist | 0.085 0.019 DBMET02164 | DBMET02164 | |
| 0.053 | 0.203 | 0.091 | Granulocyte macrophage colony stimulating factor agonist | 0.091 0.049 DBMET02164 | DBMET02164 | |
| 0.032 | 0.183 | 0.056 | Pregnane X receptor antagonist | 0.056 0.043 DBMET02164 | DBMET02164 | |
| 0.011 | 0.166 | 0.063 | Antimetabolite | 0.063 0.024 DBMET02164 | DBMET02164 | |
| 0.033 | 0.188 | 0.057 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.057 0.05 DBMET02164 | DBMET02164 | |
| 0.042 | 0.198 | 0.131 | Sphingosine 1-phosphate receptor antagonist | 0.131 0.01 DBMET02164 | DBMET02164 | |
| 0.029 | 0.185 | 0.106 | Sphingosine 1-phosphate receptor 1 antagonist | 0.106 0.008 DBMET02164 | DBMET02164 | |
| 0.032 | 0.189 | 0.148 | NMDA receptor antagonist | 0.148 0.025 DBMET02164 | DBMET02164 | |
| 0.008 | 0.165 | 0.057 | Kainate receptor antagonist | 0.057 0.017 DBMET02164 | DBMET02164 | |
| 0.025 | 0.183 | 0.281 | Histidine decarboxylase inhibitor | 0.281 0.007 DBMET02164 | DBMET02164 | |
| 0.061 | 0.218 | 0.285 | Aldehyde dehydrogenase inhibitor | 0.285 0.013 DBMET02164 | DBMET02164 | |
| 0.106 | 0.264 | 0.182 | Catenin beta inhibitor | 0.182 0.049 DBMET02164 | DBMET02164 | |
| 0.01 | 0.168 | 0.062 | Ribonucleotide reductase inhibitor | 0.062 0.035 DBMET02164 | DBMET02164 | |
| 0.005 | 0.164 | 0.049 | NMDA receptor glycine site antagonist | 0.049 0.006 DBMET02164 | DBMET02164 | |
| 0.007 | 0.166 | 0.027 | Integrin alphaVbeta3 antagonist | 0.027 0.01 DBMET02164 | DBMET02164 | |
| 0.022 | 0.181 | 0.096 | Aconitate hydratase inhibitor | 0.096 0.009 DBMET02164 | DBMET02164 | |
| 0.067 | 0.226 | 0.119 | Interleukin 8 antagonist | 0.119 0.062 DBMET02164 | DBMET02164 | |
| 0.105 | 0.265 | 0.2 | Neurotensin receptor agonist | 0.2 0.035 DBMET02164 | DBMET02164 | |
| 0.022 | 0.182 | 0.04 | GABA B receptor antagonist | 0.04 0.034 DBMET02164 | DBMET02164 | |
| 0.008 | 0.168 | 0.025 | Liver X receptor beta antagonist | 0.025 0.024 DBMET02164 | DBMET02164 | |
| 0.055 | 0.217 | 0.1 | Carbonic anhydrase XV inhibitor | 0.1 0.067 DBMET02164 | DBMET02164 | |
| 0.01 | 0.173 | 0.059 | Ribonucleoside-diphosphate reductase inhibitor | 0.059 0.035 DBMET02164 | DBMET02164 | |
| 0.015 | 0.183 | 0.102 | NMDA 2 receptor antagonist | 0.102 0.031 DBMET02164 | DBMET02164 | |
| 0.089 | 0.258 | 0.151 | Sphingosine 1-phosphate receptor 5 antagonist | 0.151 0.059 DBMET02164 | DBMET02164 | |
| 0.059 | 0.23 | 0.155 | Adenylate kinase inhibitor | 0.155 0.024 DBMET02164 | DBMET02164 | |
| 0.005 | 0.179 | 0.019 | Vitronectin receptor antagonist | 0.019 0.016 DBMET02164 | DBMET02164 | |
| 0.007 | 0.182 | 0.045 | Kainate receptor 2 antagonist | 0.045 0.018 DBMET02164 | DBMET02164 | |
| 0.038 | 0.213 | 0.101 | Peroxisome proliferator-activated receptor gamma antagonist | 0.101 0.015 DBMET02164 | DBMET02164 | |
| 0.051 | 0.226 | 0.154 | Caspase 3 inhibitor | 0.154 0.025 DBMET02164 | DBMET02164 | |
| 0.057 | 0.234 | 0.134 | DOPA decarboxylase inhibitor | 0.134 0.032 DBMET02164 | DBMET02164 | |
| 0.014 | 0.196 | 0.064 | Membrane dipeptidase inhibitor | 0.064 0.009 DBMET02164 | DBMET02164 | |
| 0.01 | 0.193 | 0.035 | ATP citrate lysase inhibitor | 0.035 0.018 DBMET02164 | DBMET02164 | |
| 0.012 | 0.195 | 0.097 | NMDA 2C receptor antagonist | 0.097 0.017 DBMET02164 | DBMET02164 | |
| 0.069 | 0.253 | 0.145 | Amyloid beta precursor protein antagonist | 0.145 0.107 DBMET02164 | DBMET02164 | |
| 0.013 | 0.198 | 0.046 | Collagenase inhibitor | 0.046 0.043 DBMET02164 | DBMET02164 | |
| 0.049 | 0.237 | 0.173 | Alkaline phosphatase inhibitor | 0.173 0.046 DBMET02164 | DBMET02164 | |
| 0.022 | 0.21 | 0.158 | Phenylalanine 4-hydroxylase inhibitor | 0.158 0.011 DBMET02164 | DBMET02164 | |
| 0.027 | 0.216 | 0.055 | Dihydroorotate oxidase inhibitor | 0.055 0.037 DBMET02164 | DBMET02164 | |
| 0.049 | 0.239 | 0.146 | Bone formation stimulant | 0.146 0.062 DBMET02164 | DBMET02164 | |
| 0.046 | 0.237 | 0.108 | DNA polymerase I inhibitor | 0.108 0.078 DBMET02164 | DBMET02164 | |
| 0.034 | 0.226 | 0.07 | Caspase 9 inhibitor | 0.07 0.032 DBMET02164 | DBMET02164 | |
| 0.038 | 0.23 | 0.074 | Chymotrypsin inhibitor | 0.074 0.064 DBMET02164 0.073 0.064 DBMET02151 | DBMET02164 | |
| 0.079 | 0.271 | 0.302 | Platelet antagonist | 0.302 0.052 DBMET02164 | DBMET02164 | |
| 0.017 | 0.21 | 0.126 | Prostaglandin-E synthase inhibitor | 0.126 0.018 DBMET02164 | DBMET02164 | |
| 0.01 | 0.204 | 0.077 | Ornithine carbamoyltransferase inhibitor | 0.077 0.023 DBMET02164 | DBMET02164 | |
| 0.002 | 0.197 | 0.012 | Thyroid hormone beta agonist | 0.012 0.004 DBMET02164 | DBMET02164 | |
| 0.024 | 0.22 | 0.089 | Botulinum neurotoxin type A inhibitor | 0.089 0.012 DBMET02164 | DBMET02164 | |
| 0.103 | 0.3 | 0.221 | Transcription factor NF kappa B inhibitor | 0.221 0.15 DBMET02164 | DBMET02164 | |
| 0.035 | 0.233 | 0.145 | Expectorant | 0.145 0.038 DBMET02164 | DBMET02164 | |
| 0.005 | 0.203 | 0.037 | Cholecystokinin antagonist | 0.037 0.031 DBMET02164 | DBMET02164 | |
| 0.009 | 0.209 | 0.043 | Thyroid hormone agonist | 0.043 0.005 DBMET02164 | DBMET02164 | |
| 0.018 | 0.218 | 0.043 | Glutamate (mGluR group III) agonist | 0.043 0.029 DBMET02164 | DBMET02164 | |
| 0.014 | 0.216 | 0.036 | Glutamate (mGluR3) agonist | 0.036 0.015 DBMET02164 | DBMET02164 | |
| 0.033 | 0.237 | 0.199 | Aminopeptidase B inhibitor | 0.199 0.021 DBMET02164 | DBMET02164 | |
| 0.013 | 0.219 | 0.093 | NMDA receptor subunit 3B antagonist | 0.093 0.012 DBMET02164 | DBMET02164 | |
| 0.014 | 0.219 | 0.054 | Sphingosine 1-phosphate receptor agonist | 0.054 0.021 DBMET02164 | DBMET02164 | |
| 0.015 | 0.221 | 0.047 | Dihydroorotase inhibitor | 0.047 0.027 DBMET02164 | DBMET02164 | |
| 0.01 | 0.226 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.018 DBMET02164 | DBMET02164 | |
| 0.022 | 0.238 | 0.162 | Glutamate decarboxylase inhibitor | 0.162 0.011 DBMET02164 | DBMET02164 | |
| 0.025 | 0.244 | 0.067 | Thrombin inhibitor | 0.067 0.059 DBMET02164 | DBMET02164 | |
| 0.008 | 0.228 | 0.089 | NMDA receptor subunit 3A antagonist | 0.089 0.01 DBMET02164 | DBMET02164 | |
| 0.051 | 0.272 | 0.106 | Hematopoietic | 0.106 0.03 DBMET02164 | DBMET02164 | |
| 0.038 | 0.259 | 0.11 | Anabolic | 0.11 0.049 DBMET02164 | DBMET02164 | |
| 0.015 | 0.239 | 0.079 | Phosphofructokinase-1 inhibitor | 0.079 0.042 DBMET02164 | DBMET02164 | |
| 0.011 | 0.236 | 0.093 | Prostaglandin antagonist | 0.093 0.019 DBMET02164 | DBMET02164 | |
| 0.007 | 0.233 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.037 0.005 DBMET02151 | DBMET02151 | |
| 0.013 | 0.239 | 0.05 | Carbonic anhydrase XIV inhibitor | 0.05 0.032 DBMET02164 | DBMET02164 | |
| 0.022 | 0.253 | 0.072 | Heparanase inhibitor | 0.072 0.01 DBMET02164 | DBMET02164 | |
| 0.071 | 0.307 | 0.14 | Melanin inhibitor | 0.14 0.097 DBMET02164 | DBMET02164 | |
| 0.014 | 0.255 | 0.046 | Lysophosphatidic acid 3 receptor antagonist | 0.046 0.042 DBMET02164 | DBMET02164 | |
| 0.006 | 0.248 | 0.043 | Sphingosine 1-phosphate receptor 1 agonist | 0.043 0.028 DBMET02164 | DBMET02164 | |
| 0.013 | 0.257 | 0.071 | Plasminogen activator inhibitor | 0.051 0.047 DBMET02164 0.071 0.031 DBMET02151 | DBMET02151 | |
| 0.013 | 0.259 | 0.073 | Alcohol oxidase inhibitor | 0.073 0.027 DBMET02164 | DBMET02164 | |
| 0.017 | 0.263 | 0.049 | Beta 2 adrenoreceptor antagonist | 0.049 0.038 DBMET02164 | DBMET02164 | |
| 0.015 | 0.264 | 0.064 | Leukotriene antagonist | 0.064 0.046 DBMET02164 | DBMET02164 | |
| 0.011 | 0.261 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.027 DBMET02164 | DBMET02164 | |
| 0.039 | 0.294 | 0.201 | Amylase inhibitor | 0.201 0.044 DBMET02164 | DBMET02164 | |
| 0.016 | 0.271 | 0.04 | Glutamate (mGluR8) agonist | 0.04 0.023 DBMET02164 | DBMET02164 | |
| 0.028 | 0.283 | 0.091 | Ornithine decarboxylase inhibitor | 0.091 0.054 DBMET02164 | DBMET02164 | |
| 0.006 | 0.261 | 0.032 | Prostacyclin antagonist | 0.032 0.024 DBMET02164 | DBMET02164 | |
| 0.013 | 0.269 | 0.065 | Argininosuccinate synthase inhibitor | 0.065 0.033 DBMET02164 | DBMET02164 | |
| 0.007 | 0.267 | 0.061 | Peroxisome proliferator-activated receptor alpha agonist | 0.061 0.026 DBMET02164 | DBMET02164 | |
| 0.009 | 0.279 | 0.034 | Peroxisome proliferator-activated receptor delta antagonist | 0.034 0.021 DBMET02164 | DBMET02164 | |
| 0.016 | 0.294 | 0.165 | Porphobilinogen synthase inhibitor | 0.165 0.017 DBMET02164 | DBMET02164 | |
| 0.068 | 0.353 | 0.13 | Interferon gamma antagonist | 0.13 0.111 DBMET02164 | DBMET02164 | |
| 0.009 | 0.295 | 0.044 | Glutamate (mGluR3) antagonist | 0.044 0.017 DBMET02164 | DBMET02164 | |
| 0.043 | 0.338 | 0.1 | Photosensitizer | 0.1 0.088 DBMET02164 | DBMET02164 | |
| 0.012 | 0.317 | 0.077 | Glucagon-like peptide 1 agonist | 0.077 0.036 DBMET02164 | DBMET02164 | |
| 0.036 | 0.341 | 0.118 | Carbonic anhydrase III inhibitor | 0.118 0.046 DBMET02164 | DBMET02164 | |
| 0.015 | 0.324 | 0.056 | Angiotensin-converting enzyme inhibitor | 0.056 0.035 DBMET02164 | DBMET02164 | |
| 0.013 | 0.322 | 0.059 | Carbonic anhydrase V inhibitor | 0.059 0.055 DBMET02164 | DBMET02164 | |
| 0.041 | 0.351 | 0.196 | Phospholipase A2 inhibitor | 0.196 0.045 DBMET02164 | DBMET02164 | |
| 0.016 | 0.326 | 0.063 | Carbonic anhydrase VA inhibitor | 0.063 0.055 DBMET02164 | DBMET02164 | |
| 0.027 | 0.341 | 0.089 | Carbonic anhydrase VI inhibitor | 0.089 0.047 DBMET02164 | DBMET02164 | |
| 0.045 | 0.359 | 0.244 | Insulin sensitizer | 0.244 0.038 DBMET02164 | DBMET02164 | |
| 0.028 | 0.343 | 0.069 | Keratolytic | 0.069 0.066 DBMET02164 | DBMET02164 | |
| 0.027 | 0.344 | 0.069 | Adenine nucleotide translocase inhibitor | 0.069 0.016 DBMET02164 | DBMET02164 | |
| 0.053 | 0.387 | 0.142 | Interleukin 6 antagonist | 0.142 0.101 DBMET02164 | DBMET02164 | |
| 0.019 | 0.368 | 0.16 | Alcohol dehydrogenase inhibitor | 0.16 0.018 DBMET02164 | DBMET02164 | |
| 0.004 | 0.379 | 0.022 | Prostaglandin D2 antagonist | 0.022 0.017 DBMET02164 | DBMET02164 | |
| 0.047 | 0.426 | 0.192 | Insulin secretagoues | 0.192 0.04 DBMET02164 | DBMET02164 | |
| 0.016 | 0.397 | 0.064 | Prostaglandin F2 alpha antagonist | 0.064 0.039 DBMET02164 | DBMET02164 | |
| 0.1 | 0.481 | 0.282 | Interleukin 2 agonist | 0.282 0.088 DBMET02164 | DBMET02164 | |
| 0.014 | 0.414 | 0.036 | Glutamate (mGluR8) antagonist | 0.036 0.024 DBMET02164 | DBMET02164 | |
| 0.023 | 0.428 | 0.109 | Estrogen receptor beta antagonist | 0.109 0.048 DBMET02152 | DBMET02152 | |
| 0.021 | 0.432 | 0.091 | Aminoacyl-tRNA synthetase inhibitor | 0.091 0.057 DBMET02164 | DBMET02164 | |
| 0.045 | 0.488 | 0.163 | Hepatoprotectant | 0.163 0.096 DBMET02164 | DBMET02164 | |
| 0.076 | 0.523 | 0.303 | Apoptosis antagonist | 0.303 0.083 DBMET02164 | DBMET02164 | |
| 0.016 | 0.475 | 0.105 | Bronchodilator | 0.105 0.058 DBMET02150 | DBMET02150 | |
| 0.005 | 0.477 | 0.097 | Aldose reductase inhibitor | 0.097 0.019 DBMET02164 | DBMET02164 | |
| 0.035 | 0.514 | 0.35 | Tumour necrosis factor alpha release inhibitor | 0.35 0.038 DBMET02150 | DBMET02150 | |
| 0.055 | 0.534 | 0.219 | Antibacterial | 0.219 0.208 DBMET02164 | DBMET02164 | |
| 0.025 | 0.511 | 0.113 | Estrogen antagonist | 0.113 0.069 DBMET02152 | DBMET02152 | |
| 0.005 | 0.494 | 0.087 | Peroxisome proliferator-activated receptor gamma agonist | 0.087 0.036 DBMET02164 | DBMET02164 | |
| 0.048 | 0.554 | 0.254 | Hypoglycemic | 0.254 0.075 DBMET02164 | DBMET02164 | |
| 0.018 | 0.541 | 0.216 | Thrombolytic | 0.216 0.045 DBMET02164 | DBMET02164 | |
| 0.039 | 0.572 | 0.208 | Immunosuppressant | 0.208 0.189 DBMET02164 | DBMET02164 | |
| 0.02 | 0.568 | 0.211 | Angiogenesis stimulant | 0.211 0.089 DBMET02164 | DBMET02164 | |
| 0.019 | 0.57 | 0.196 | Hypolipemic | 0.196 0.097 DBMET02164 | DBMET02164 | |
| 0.05 | 0.639 | 0.42 | Cyclophilin D inhibitor | 0.42 0.08 DBMET02164 | DBMET02164 | |
| 0.006 | 0.651 | 0.044 | Plasminogen activator inhibitor antagonist | 0.044 0.041 DBMET02164 | DBMET02164 | |
| 0.006 | 0.706 | 0.126 | Protein-tyrosine phosphatase inhibitor | 0.126 0.106 DBMET02164 | DBMET02164 | |
| 0.039 | 0.744 | 0.447 | Sodium/bile acid cotransporter inhibitor | 0.447 0.008 DBMET02164 | DBMET02164 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |